Drug recall
Apheresis Platelets, Leukocytes Reduced
FDA recall event 91732 · Class II · Vitalant
Key facts
| Event ID | 91732 |
|---|---|
| Recall numbers | B-0234-2023, B-0235-2023, B-0236-2023 |
| Recalling firm | Vitalant |
| Product type | Biologics |
| Products | Apheresis Platelets, Leukocytes Reduced, Apheresis Platelets, Leukocytes Reduced, Pathogen Reduced, Apheresis Red Blood Cells, Leukocytes Reduced |
| Classification | Class II |
| Status | Terminated |
| Voluntary or mandated | Voluntary: Firm Initiated |
| Reason for recall | Blood Products, collected in a manner that compromises the sterility of the collection system, were distributed. |
| Initiation date | Dec 3, 2022 |
| Report date | Mar 8, 2023 |
| Termination date | Mar 1, 2023 |
| City | Denver |
| State | CO |
| Country | United States |
| FEI number | 3000210247 |
At a glance
- 1–9 Products in this recall
- 10–99 FDA inspections of this firm (FEI)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA drug and product recalls
FDA enforcement reports list recalls of drugs, biologics, foods and other FDA-regulated products, classified by the potential health hazard.
Source: U.S. Food and Drug Administration (FDA), Enforcement Reports · Source date: